FDA product code NBW: System, Test, Blood Glucose, Over The Counter
NBW is the FDA product code for system, test, blood glucose, over the counter. It is a Class II device, regulated under 21 CFR 862.1345 and reviewed by the Clinical Chemistry panel. FDA has cleared 514 510(k) submissions under NBW, 32 in the last five years, from 131 different applicants. The average 510(k) review took 195 days (median 153); 214 days on average over the last three years. FDA has posted 137 recalls for NBW devices, 9 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | System, Test, Blood Glucose, Over The Counter |
| Device class | Class II |
| Regulation | 21 CFR 862.1345 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
510(k) clearances per year for NBW
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 25 | 258 |
| 2018 | 19 | 167 |
| 2019 | 10 | 153 |
| 2020 | 7 | 145 |
| 2021 | 7 | 416 |
| 2022 | 12 | 426 |
| 2023 | 5 | 264 |
| 2024 | 7 | 263 |
| 2025 | 2 | 198 |
| 2026 | 6 | 180 |
Compare with all 510(k) review times · Search every NBW clearance
Top NBW applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Taidoc Technology Corporation | 65 | 2022-06-16 |
| I-Sens, Inc. | 22 | 2026-10-02 |
| Bionime Corporation | 18 | 2024-11-04 |
| Apex BioTechnology Corp. | 18 | 2022-12-21 |
| Abbott Diabetes Care, Inc. | 18 | 2017-09-27 |
126 more applicants have NBW clearances. See the full list in Caduvo.
Most recent NBW clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260738 | Changsha Sinocare, Inc. | Safe AQ Easy Blood Glucose Monitoring System; Safe AQ Care Blood Glucose Monitoring System | 2026-10-30 | 238 |
| K261293 | EPS Bio Technology Corp. | EASYMAX Voice Blood Glucose Monitoring System | 2026-10-23 | 186 |
| K260687 | Vivachek Biotech (Hangzhou) Co., Ltd. | VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual Monitoring System. | 2026-10-09 | 220 |
| K260689 | I-Sens, Inc. | CVS Advanced PLUS Blood Glucose Monitoring System | 2026-10-02 | 213 |
| K260545 | Ascensia Diabetes Care | CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System; CONTOUR® NEXT ONE Blood Glucose Monitoring System | 2026-08-27 | 190 |
Recalls for NBW devices
137 product recalls in 75 recall events; 9 initiated in the last five years and 18 still open. Most recent: 2026-02-06.
| Year | Recalls |
|---|---|
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 16 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 4 |
Frequently asked questions
What is FDA product code NBW?
NBW is the FDA product code for system, test, blood glucose, over the counter. It is a Class II device, regulated under 21 CFR 862.1345 and reviewed by the Clinical Chemistry panel.
What device class is NBW?
Class II, regulation 21 CFR 862.1345. Typical premarket route: 510(k).
How long does a 510(k) take for product code NBW?
Across 514 cleared submissions the average was 195 days from receipt to decision (median 153).
Which companies have the most NBW clearances?
Taidoc Technology Corporation (65); I-Sens, Inc. (22); Bionime Corporation (18); Apex BioTechnology Corp. (18); Abbott Diabetes Care, Inc. (18).
Have NBW devices been recalled?
Yes: 137 product recalls across 75 recall events; the most recent began 2026-02-06.
Next steps
- Run an FDA pathway report with predicate devices for product code NBW
- Run a recall and safety report across every NBW manufacturer
- Watch product code NBW for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times